|
11 Sep 2025 |
Ashok Leyland
|
Consensus Share Price Target
|
133.02 |
140.21 |
- |
5.41 |
buy
|
|
|
|
|
28 Aug 2025
|
Ashok Leyland
|
Geojit BNP Paribas
|
133.02
|
150.00
|
129.82
(2.46%)
|
12.76 |
Buy
|
|
|
AL is coming up with several new MHCV and LCV products in H2FY26. These include heavy -duty tippers, tractor trailers and multi-axle vehicles with industry-best peak power and torque and other premium features. The company is also foraying into the LNG segment and a bi-fuel LCV product this FY. The new Andhra Pradesh plant is ramping to 200 units/ month by year-end. The company is targeting production of 1650 units/month from the current rate of 950/month. Management is confident in the H2 uptrend, driven by new...
|
|
20 Aug 2025
|
Ashok Leyland
|
Deven Choksey
|
133.02
|
155.00
|
133.28
(-0.20%)
|
16.52 |
Buy
|
|
|
Management retained its guidance of mid-single digit MHCV volume growth and slightly higher growth in the LCV segment for FY26E, led by a stronger 2HFY26E driven by replacement demand, higher government capex, easing steel costs, and new product launches across MHCV, LCV, and alternate fuel platforms.
|
|
18 Aug 2025
|
Ashok Leyland
|
Axis Direct
|
133.02
|
135.00
|
131.76
(0.96%)
|
Target met |
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
15 Aug 2025
|
Ashok Leyland
|
Motilal Oswal
|
133.02
|
141.00
|
121.96
(9.07%)
|
6.00 |
Buy
|
|
|
Ashok Leyland’s (AL) 1Q PAT stood at INR5.9b, marginally ahead of our estimate of INR5.8b, led by a slight beat on margins (30bp) and higher other income.
|
|
26 May 2025
|
Ashok Leyland
|
BOB Capital Markets Ltd.
|
133.02
|
276.00
|
239.89
(-44.55%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Q4FY25 revenue grew 6%/26% YoY/QoQ to Rs 119.1bn, aided by volume gains of 4%/27% YoY/QoQ, while realisations stay put
|
|
05 Mar 2025
|
Ashok Leyland
|
Geojit BNP Paribas
|
133.02
|
251.00
|
209.21
(-36.42%)
|
Target met |
Buy
|
|
|
|
|
13 Feb 2025
|
Ashok Leyland
|
BOB Capital Markets Ltd.
|
133.02
|
274.00
|
217.07
(-38.72%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Q3FY25 revenue grew 2%/8% YoY/QoQ to Rs 94.76bn, helped by realisation gains of 4%/6% YoY/QoQ while volume was listless
|
|
13 Feb 2025
|
Ashok Leyland
|
Prabhudas Lilladhar
|
133.02
|
244.00
|
217.07
(-38.72%)
|
Target met |
Accumulate
|
|
|
|
|
13 Feb 2025
|
Ashok Leyland
|
Anand Rathi
|
133.02
|
260.00
|
217.07
(-38.72%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Surpassing our Rs11.3bn estimate on more-than-expected revenue and less-than-anticipated other expenses, Ashok Leyland’s Q3 EBITDA grew 9% y/y to Rs12.1bn.
|
|
13 Feb 2025
|
Ashok Leyland
|
Axis Direct
|
133.02
|
245.00
|
217.07
(-38.72%)
|
Target met |
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
13 Feb 2025
|
Ashok Leyland
|
Prabhudas Lilladhar
|
133.02
|
244.00
|
217.07
(-38.72%)
|
Target met |
Accumulate
|
|
|
Ashok Leyland's reported strong Q3FY25 performance with revenue growth being 3% better than PLe/consensus estimates. During Q3FY25, its volume decline by 1.4% YoY, however, realization increased by 3.7% YoY with the main cause being discipline on discounts, better mix of M&HCV products and healthy spares revenue. EBITDA margin was better than PLe/consensus expectations (12.1%/11.9%) at 12.8%, aided by cost mitigating measures to drive overall profitability. Sharp decline in other income was offset by decline in interest...
|
|
16 Dec 2024
|
Ashok Leyland
|
Sharekhan
|
133.02
|
268.00
|
234.84
(-43.36%)
|
Pre-Bonus/ Split |
Buy
|
|
|
We reiterate our BUY rating on Ashok Leyland (ALL) on (1) its focus on profitability over plain vanilla volume growth strategy, (2) sustaining EBITDA margin over the 10% mark, (3) passing on cost inflation to customers to save profitability
|
|
11 Nov 2024
|
Ashok Leyland
|
BP Wealth
|
133.02
|
|
224.34
(-40.71%)
|
Pre-Bonus/ Split |
Results Update
|
|
|
|
|
11 Nov 2024
|
Ashok Leyland
|
Axis Direct
|
133.02
|
250.00
|
224.34
(-40.71%)
|
Target met |
Buy
|
|
|
We upgrade our rating from HOLD to BUY on the stock from a long term perspective
|
|
09 Nov 2024
|
Ashok Leyland
|
Emkay
|
133.02
|
275.00
|
221.89
(-40.05%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Despite muted volumes in 2Q, AL reported 100bps margin expansion to 11.6% on sustained pricing discipline, material cost controls, and growth in the non-MHCV portfolio.
|
|
09 Nov 2024
|
Ashok Leyland
|
BOB Capital Markets Ltd.
|
133.02
|
279.00
|
221.89
(-40.05%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Q2FY25 revenue grew 9% YoY to Rs 87.6bn (up 2% QoQ), helped by flat realisations YoY while volume fell by 9%
|
|
08 Nov 2024
|
Ashok Leyland
|
Sharekhan
|
133.02
|
268.00
|
221.89
(-40.05%)
|
Pre-Bonus/ Split |
Buy
|
|
|
With sharp gross margin expansion and healthy traction in non-vehicle business ALL beats estimates in Q2FY25.
|
|
10 Sep 2024
|
Ashok Leyland
|
Sharekhan
|
133.02
|
285.00
|
248.25
(-46.42%)
|
Pre-Bonus/ Split |
Buy
|
|
|
We reiterate our Buy recommendation on Ashok Leyland Ltd (ALL) based on healthy momentum in the MHCV industry in H2FY25 as compared to the first half.
|
|
02 Aug 2024
|
Ashok Leyland
|
Geojit BNP Paribas
|
133.02
|
280.00
|
250.15
(-46.82%)
|
Pre-Bonus/ Split |
Buy
|
|
|
|
|
29 Jul 2024
|
Ashok Leyland
|
Axis Direct
|
133.02
|
230.00
|
256.35
(-48.11%)
|
Target met |
Hold
|
|
|
We maintain our HOLD rating on the stock with a limited upside potential.
|